Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
Lung cancer is one of the leading causes of cancer-related death.Lung cancer mortality has decreased over the past decade, which is partly attributed to improved treatments.Curative surgery for patients with XYLITOL early-stage lung cancer is the standard of care, but not all surgical treatments have a good prognosis.Adjuvant and neoadjuvant chemot